nach oben

Journal of Bone and Mineral Metabolism

Erschienen in:

01.11.2010 | Original Article

Treatment of experimental osteonecrosis of the hip in adult rabbits with a single local injection of recombinant human FGF-2 microspheres

verfasst von: Yutaka Kuroda, Haruhiko Akiyama, Keiichi Kawanabe, Yasuhiko Tabata, Takashi Nakamura

Erschienen in: Journal of Bone and Mineral Metabolism | Ausgabe 6/2010

Einloggen, um Zugang zu erhalten

Abstract

Basic fibroblast growth factor (FGF-2) exerts anabolic actions on bone formation. Here we investigated the potential effects of recombinant human FGF-2 (rhFGF-2) on the repair process of osteonecrosis of the femoral head (ONFH) and the development of secondary osteoarthritis (OA) in adult rabbits. ONFH was induced by intramuscular injection with methylprednisolone, and vascular occlusion of the capital femoral epiphysis by electrocoagulation, in adult Japanese white rabbits. Animals were randomized into two groups: treatment and control. The treatment group was given a single local injection into the femoral head of 100 μg rhFGF-2 in 100 μl gelatin hydrogel microspheres 8 weeks after the ONFH procedure, and the control group was given phosphate-buffered saline in 100 μl gelatin hydrogel microspheres. Morphological, histopathological, and radiologic analyses, including micro-computed tomography scans and magnetic resonance imaging, showed collapse of the femoral head and progression of articular cartilage degeneration in the control group at 16 weeks after the single local injection of rhFGF-2. In contrast, rhFGF-2 treatment resulted in new bone formation in the femoral head and prevented the femoral head from collapsing. In addition, the changes in OA, assessed by the modified Mankin score, was significantly lower in the treatment group. Our results indicate that a single local injection of rhFGF-2 microspheres promoted the repair of the osteonecrotic femoral head and inhibited femoral head collapse and OA progression. rhFGF-2 may be a promising strategy for the treatment of ONFH.

Hernigou P, Ooignard A, Nogier A, Manicom O (2004) Fate of very small asymptomatic stage-I osteonecrotic lesions of the hip. J Bone Joint Surg Am 86:2589–2593PubMed

Mont MA, Jones LC, Hngerford DS (2006) Nontraumatic osteonecrosis of the femoral head: ten years later. J Bone Joint Surg Am 88:1117–1132CrossRefPubMed

Marker DR, Seylee TM, McGrath MS, Delanois RE, Ulrich SD, Mont MA (2008) Treatment of early stage osteonecrosis of the femoral head. J Bone Joint Surg Am 90:175–187CrossRefPubMed

Mont MA, Jones LC, Einhorn TA, Hungerford DS, Reddi AH (1998) Osteonecrosis of the femoral head: potential treatment with growth and differentiation factors. Clin Orthop Relat Res 355:314–335CrossRef

Lieberman JR, Conduah A, Urist MR (2004) Treatment of osteonecrosis of the femoral head with core decompression and human bone morphogenetic protein. Clin Orthop Relat Res 429:139–145CrossRefPubMed

Gangji V, Hauzeur JP, Matos C, De Maertelaer V, Toungouz M, Lambermont M (2004) Treatment of osteonecrosis of the femoral head with implantation of autologous bone-marrow cells: a pilot study. J Bone Joint Surg Am 86:1153–1160PubMed

Hernigou P, Beaujean F (2002) Treatment of osteonecrosis with autologous bone marrow grafting. Clin Orthop Relat Res 405:14–23CrossRefPubMed

Desai MM, Sonone S, Bhasme V (2005) Efficacy of alendronate in the treatment of avascular necrosis of the hip. Rheumatology 44:1331–1332CrossRefPubMed

Lai KA, Shen WJ, Yang CY, Shao CJ, Hsu JT, Lin RM (2005) The use of alendronate to prevent early collapse of the femoral head in patients with nontraumatic osteonecrosis. J Bone Joint Surg Am 87:2155–2159CrossRefPubMed

10.

Cui Q, Wang CJ, Su CC, Balian G (1997) Lovastatin prevents steroid induced adipogenesis and osteonecrosis. Clin Orthop Relat Res 344:8–19CrossRefPubMed

11.

Pritchett JW (2001) Statin therapy decreases the risk of osteonecrosis in patients receiving steroids. Clin Orthop Relat Res 386:173–178CrossRefPubMed

12.

Canalis E, Centrella M, McCarthy T (1988) Effects of basic fibroblast growth factor on bone formation in vitro. J Clin Invest 81:1572–1577CrossRefPubMed

13.

Lieberman JR, Daluiski A, Einhorn TA (2002) The role of growth factors in the repair of bone biology and clinical applications. J Bone Joint Surg Am 84:1032–1044PubMed

14.

Itoh N, Orniz DM (2004) Evolution of the Fgf and Fgfr gene families. Trends Genet 20:563–569CrossRefPubMed

15.

Kato T, Kawaguchi H, Hanada K, Aoyama Y, Nakamura T, Kuzutani K, Tamura M, Kurokawa T, Nakamura K (1998) Single local injection of recombinant fibroblast growth factor-2 stimulates healing of segmental bone defects in rabbit. J Orthop Res 16:654–659CrossRefPubMed

16.

Nakamura T, Hara Y, Tagawa M, Yuge T, Fukuda H, Nigi H (1998) Recombinant human basic fibroblast growth factor accelerates fracture healing by enhancing callus remodeling in experimental dog tibial fracture. J Bone Miner Res 13:942–949CrossRefPubMed

17.

Chen WJ, Jingushi W, Aoyama I, Anzai J, Hirata G, Tamura M, Iwamoto Y (2004) Effects of FGF-2 on metaphyseal fracture in rabbit tibiae. J Bone Miner Metab 22:303–309CrossRefPubMed

18.

Tabata Y, Nagano A, Ikada Y (1999) Biodegradation of hydrogel carrier incorporating fibroblast growth factor. Tissue Eng 5:127–147CrossRefPubMed

19.

Yamamoto M, Ikeda Y, Tabata Y (2001) Controlled release of growth factors based on biodegradation of gelatin hydrogel. J Biomater Sci Polym Ed 12:77–88CrossRefPubMed

20.

Tabata Y (2003) Tissue regeneration based on growth factor release. Tissue Eng 9(suppl 1):S5–S15CrossRefPubMed

21.

Tabata Y, Yamada K, Miyamoto S, Nagata I, Kikuchi H, Aoyama I, Tamura M, Ikada Y (1998) Bone regeneration by basic fibroblast growth factor complexed with biodegradable hydrogel. Biomaterials 19:807–815CrossRefPubMed

22.

Tabata Y, Hijikata S, Muniruzzaman M, Ikada Y (1999) Neovascularization through biodegradable gelatin microspheres incorporating basic fibroblast growth factor. J Biomater Sci Polym Ed 10:79CrossRefPubMed

23.

Sakakibara Y, Nishimura K, Tambara K, Yamamoto M, Lu F, Tabata Y, Komeda M (2001) Prevascularization with gelatin microspheres containing basic fibroblast growth factor enhances the benefits of cardiomyocyte transplantation. J Thorac Cardiovasc Surg 124:50CrossRef

24.

Kawaguchi H, Jingushi S, Izumi M, Fukunaga M, Matsushita T, Nakamura T, Mizuno K, Nakamura T, Nakamura K (2007) Local application of recombinant human fibroblast growth factor-2 on bone repair: a dose-escalation prospective trial on patients with osteotomy. J Orthop Res 25:480–487CrossRefPubMed

25.

Tabata Y, Yamada K, Hong L, Miyamoto S, Hashimoto N, Ikada Y (1999) Skull bone regeneration in primates in response to basic fibroblast growth factor. J Neurosurg 91:851CrossRefPubMed

26.

Norman D, Reis D, Zinman G, Misselevich I, Boss JH (1998) Vascular deprivation-induced necrosis of the femoral head of the rat. An experimental model of avascular osteonecrosis in the skeletally immature individual or Legg–Perthes disease. Int J Exp Pathol 79:173–181CrossRefPubMed

27.

Hofstaetter JG, Wang J, Yan J, Glimcher MJ (2009) The effects of allendronate in the treatment of experimental osteonecrosis of the hip on adult rabbits. Osteoarthritis Cartil 17:362–370CrossRef

28.

Okano K, Enomoto H, Osaki M, Shindo H (2008) Rotational acetabular osteotomy for advanced osteoarthritis secondary to developmental dysplasia of the hip. J Bone Joint Surg Br 90:23–26PubMed

29.

Magnussen RA, Guilak F, Vail TP (2005) Articular cartilage degeneration in post-collapse osteonecrosis of the femoral head. Radiographic staging, macroscopic grading, and histologic changes. J Bone Joint Surg Am 87:1272–1277CrossRefPubMed

30.

Ficat RP, Arlet J (1980) Functional investigation of bone under normal conditions. In: Hungerford DS (ed) Ischemia and necrosis of bone. Williams & Wilkins, Baltimore, pp 29–52

31.

Otsu N (1979) A threshold selection method from gray-level histograms. IEEE Trans Syst Man Cybern 9:62–66CrossRef

32.

Mankin HJ, Dorfman H, Lippiello L, Zarins A (1971) Biochemical and metabolic abnormalities in articular cartilage from osteo-arthritic human hips. II. Correlation of morphology with biochemical and metabolic data. J Bone Joint Surg Am 53:523–537PubMed

33.

Shida JI, Jingushi S, Izumi T, Ikenoue T, Iwamoto Y (2001) Basic fibroblast growth factor regulates expression of growth factors in rat epiphyseal chondrocytes. J Orthop Res 19:259–264CrossRefPubMed

34.

Kawaguchi H, Pilbeam CC, Gronowicz G, Abreu C, Fletcher BS, Herschman HR, Raisz LG, Hurley MM (1995) Transcriptional induction of prostaglandin G/H synthase-2 by basic fibroblast growth factor. J Clin Invest 96:923–930CrossRefPubMed

35.

Collin-Osdoby P, Rothe L, Bekker S, Anderson F, Huang Y, Osdoby P (2002) Basic fibroblast growth factor stimulates osteoclast recruitment, development, and bone pit resorption in association with angiogenesis in vivo on the chick chorioallantoic membrane and activates isolated avian osteoclast resorption in vitro. J Bone Miner Res 17:1859–1871CrossRefPubMed

36.

Chikazu D, Hakeda Y, Ogata N, Nemoto K, Itabashi A, Takato T, Kumegawa M, Nakamura K, Kawaguchi H (2000) Fibroblast growth factor (FGF)-2 directly stimulates mature osteoclast function through activation of FGF receptor 1 and p42/p44 MAP kinase. J Biol Chem 6:31444–31450CrossRef

37.

Komaki H, Tanaka T, Chazono M, Kikuchi T (2006) Repair of segmental defects in rabbit tibiae using a complex β-tricalcium phosphate, type I collagen, and fibroblast growth factor-2. Biomaterials 27:5118–5126CrossRefPubMed

38.

Tsurushima H, Marushima A, Suzuki K, Oyane A, Sogo Y, Nakamura K, Matsumura A, Ito A (2010) Enhanced bone formation using hydroxyapatite ceramic coated with fibroblast growth factor-2. Acta Biomater doi:10.1016/j.actbio.2009.12.045

39.

Hungerford MW, Mont MA (2000) Potential uses of cytokines and growth factors in treatment of osteonecrosis. Orthopade 29:442–448CrossRefPubMed

40.

D’Amore PA, Smith SR (1993) Growth factor effects on cells of the vascular wall: a survey. Growth Factors 8:61–75CrossRefPubMed

41.

Ferrara N, Henzel WJ (1989) Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 161:851–858CrossRefPubMed

Titel: Treatment of experimental osteonecrosis of the hip in adult rabbits with a single local injection of recombinant human FGF-2 microspheres
verfasst von: Yutaka Kuroda
Haruhiko Akiyama
Keiichi Kawanabe
Yasuhiko Tabata
Takashi Nakamura
Publikationsdatum: 01.11.2010
Verlag: Springer Japan
Erschienen in: Journal of Bone and Mineral Metabolism / Ausgabe 6/2010
Print ISSN: 0914-8779
Elektronische ISSN: 1435-5604
DOI: https://doi.org/10.1007/s00774-010-0172-5

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2010

Endogenously produced n-3 fatty acids protect against ovariectomy induced bone loss in fat-1 transgenic mice

Densitometric and geometric measurement of the proximal femur in elderly women with and without osteoporotic vertebral fractures by volumetric quantitative multi-slice CT

Common polymorphisms rather than rare genetic variants of the Runx2 gene are associated with femoral neck BMD in Spanish women

Insufficient bilateral femoral subtrochanteric fractures in a patient receiving imatinib mesylate

Identification of oxytetracycline as a chondrogenic compound using a cell-based screening system